GlassScriptPhysician profile
Sayeeda Bilkis
NPI 1225211543
$2,016.85
in general payments reported to CMS, 2019-2025
19 companies · $102 in 2025
The $102 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $563 · 2020: $270 · 2021: $327 · 2022: $445 · 2023: $236 · 2024: $73.85 · 2025: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $411.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $598.66 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $292.52 | 2021-2022 | |
| Sanofi-Aventis U.S. LLC | $165.19 | 2019-2020 | |
| Abbott Laboratories | $155.94 | 2022-2024 | Freestyle Libre 3 |
| Janssen Pharmaceuticals, INC | $137.21 | 2019 | |
| Intuity Medical INC | $121.89 | 2022 | |
| Dexcom, INC. | $121.14 | 2020-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $98.19 | 2020-2023 | Sogroya |
| Insulet Corporation | $59.48 | 2024-2025 | Omnipod |
| Cardiovascular Systems INC. | $48.76 | 2019 | |
| Tandem Diabetes Care, INC. | $44.27 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $37.02 | 2019 | |
| Biomarin Pharmaceutical INC. | $29.10 | 2025 | Voxzogo 1.2mg |
| Horizon Therapeutics Plc | $29.01 | 2020 | |
| Beta Bionics, INC. | $20.14 | 2024 | Ilet Bionic Pancreas |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $17.68 | 2025 | |
| Medtronic, INC. | $15.56 | 2025 | Minimed 780g |
| Merck Sharp & Dohme LLC | $13.38 | 2019 | |
| Lilly USA, LLC | $11.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sayeeda Bilkis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.